Skip to content
About 280Bio
Overview
Partners
Patient Journey
Pipeline & Programs
Overview
YL-17231
YL-17424
YL-15293
Additional Programs
Publications & Presentations
Clinical Trials
Science
News
Contact
280 Bio
News
July 7, 2023
280Bio receives IND approval from the FDA for YL-17231
